World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
39535
World Ranking
9556
National Ranking
328

Maria Trojano publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Maria Trojano sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 651 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Maria Trojano D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Maria Trojano sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Maria Trojano is affiliated with the University of Bari Aldo Moro in Italy. Their research primarily focuses on Medicine, with significant contributions spanning Pathology and Forensic Medicine, Neurology, Oncology, Rheumatology, and Public Health, Environmental and Occupational Health.

The scientist's work covers a broad range of topics, including:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Acute Lymphoblastic Leukemia research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research

Frequent publication venues for Maria Trojano include:

  • Neurology
  • Multiple Sclerosis Journal
  • Journal of Neurology
  • Journal of the Neurological Sciences
  • Neurological Sciences

Frequent co-authors collaborating with Trojano are:

  • Francesco Patti
  • Maria Pia Amato
  • Pietro Iaffaldano
  • Massimo Filippi
  • Franco Granella

Some of the recent papers associated with this researcher include:

  • Multiple sclerosis progression: time for a new mechanism-driven framework, 2022, The Lancet Neurology
  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, 2021, Annals of Neurology
  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study, 2020, The Lancet Neurology
  • Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP), 2020, Journal of Neurology Neurosurgery & Psychiatry
  • Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion, 2022, Journal of Neurology

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity

    R. H.S.R. Roxburgh;S. R. Seaman;T. Masterman;A. E. Hensiek

  • Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

    M. Andersson;J. Alvarezcermeno;G. Bernardi;I. Cogato

  • The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

    Ruth Ann M Marrie;Stephen Reingold;Jeffrey A Cohen;Olaf Stuve

  • Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis

    J. William L. Brown;J. William L. Brown;J. William L. Brown;Alasdair Coles;Dana Horakova;Eva Havrdova

  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

    Maria Pia Sormani;Nicola De Rossi;Irene Schiavetti;Luca Carmisciano

  • A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

    Ruth Ann M Marrie;Jeffrey A Cohen;Olaf Stuve;Maria Trojano

  • Defining secondary progressive multiple sclerosis.

    Johannes Lorscheider;Johannes Lorscheider;Katherine Buzzard;Katherine Buzzard;Katherine Buzzard;Vilija G Jokubaitis;Vilija G Jokubaitis;Tim Spelman

  • Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

    Anna He;Bernd Merkel;James William L Brown;James William L Brown;James William L Brown;Lana Zhovits Ryerson

  • The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population:

    M P Amato;E Portaccio;B Goretti;V Zipoli

  • Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

    E Millefiorini;C Gasperini;C Pozzilli;F D'Andrea

  • Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

    Angelo Ghezzi;Roberto Bergamaschi;Vittorio Martinelli;Maria Trojano

  • New natural history of interferon‐β–treated relapsing multiple sclerosis

    Maria Trojano;Fabio Pellegrini;Aurora Fuiani;Damiano Paolicelli

  • The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study

    C. Solaro;G. Brichetto;M. P. Amato;E. Cocco

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • Cognitive and psychosocial features of childhood and juvenile MS

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.

    Luis Ruano;Emilio Portaccio;Benedetta Goretti;Claudia Niccolai

  • Cognitive and psychosocial features in childhood and juvenile MS Two-year follow-up

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

    F Patti;MP Amato;M Trojano;S Bastianello

  • Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

    Maria Trojano;Guglielmo Lucchese;Giusi Graziano;Bruce V. Taylor

Frequent Co-Authors

Helmut Butzkueven
Helmut Butzkueven Monash University
Maria Pia Amato
Maria Pia Amato University of Florence
Paolo Livrea
Paolo Livrea University of Bari Aldo Moro
Raymond Hupperts
Raymond Hupperts Maastricht University
Eva Havrdova
Eva Havrdova Charles University
Alexandre Prat
Alexandre Prat University of Montreal
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Carlo Pozzilli
Carlo Pozzilli Sapienza University of Rome
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Heinz Wiendl
Heinz Wiendl University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open doors for students interested in medicine but seeking flexible or less traditional options. For those aiming to jumpstart their nursing careers, there are easy nursing schools to get into that offer accessible admission policies and supportive learning environments.

If you prefer working behind the scenes, medical billing and coding is a growing field, and there are accredited medical billing and coding schools online with financial aid to help get you started without the burden of heavy student loans.

Upgrading nursing qualifications is another popular pathway. For Licensed Practical Nurses (LPNs) looking to advance, explore lpn to rn programs without teas test. These programs can sometimes streamline the transition without requiring additional standardized exams.

Finally, for future leaders, accelerated online programs in healthcare administration are available. Consider enrolling in the healthcare administration accelerated degree that can prepare you for advanced roles in a fraction of the time.

Best Scientists Citing Maria Trojano

Trending Scientists

Recently Published Articles